← Browse by Condition
Medical Condition
refractory aml
Total Trials
2
Recruiting Now
2
Trial Phases
Phase 1, Phase 2
NCT06737523 Phase 1
Recruiting
Chiglitazar Sodium Combined With Venetoclax and Azacitidine (CVA) for the Treatment of R/R AML
Enrollment
30 pts
Location
China
Sponsor
The First Affiliated Hospital ...
NCT06022003 Phase 2
Recruiting
Study Investigating the Efficacy and Safety of the Addition of Oral-azacitidine to Salvage Treatment by Gilteritinib in Subjects ≥18 Years of Age With Relapsed/Refractory FLT3-mutated Acute Myeloid Leukemia
Enrollment
33 pts
Location
France
Sponsor
French Innovative Leukemia Org...